Bone Biologics Corp (BBLG)

Bone Biologics Corp stock is traded at $0.3248, with a volume of 20,129. It is up +0.34% in the last 24 hours and down -32.26% over the past month. Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.